The Association Between Thyroid Differentiation Score and Survival Outcomes in Papillary Thyroid Carcinoma
The Journal of Clinical Endocrinology & Metabolism · 21.01.2025 · 110 (2) · 356-363
DOI: 10.1210/clinem/dgae532 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 01.08.2024. Verfasst von Jennifer R Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Thyroid Cancer, Papillary, Thyroid Gland, Biomarkers, Tumor. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Petrick Thyroid Cancer Research Fund.
Abstract (Originalsprache)
Context
Thyroid differentiation score (TDS), calculated based on mRNA expression levels of 16 genes controlling thyroid metabolism and function, has been proposed as a measure to quantify differentiation in papillary thyroid carcinoma (PTC).
Objective
The objective of this study is to determine whether TDS is associated with survival outcomes across patient cohorts.
Methods
Two independent cohorts of patients with PTC were used: (1) The Cancer Genome Atlas (TCGA) thyroid cancer study (N = 372), (2) MD Anderson Cancer Center (MDACC) cohort (N = 111). The primary survival outcome of interest was progression-free interval (PFI). Association with overall survival (OS) was also explored. The Kaplan–Meier method and Cox proportional hazards models were used for survival analyses.
Results
In both cohorts, TDS was associated with tumor and nodal stage at diagnosis as well as tumor driver mutation status. High TDS was associated with longer PFI on univariable analyses across cohorts. After adjusting for overall stage, TDS remained significantly associated with PFI in the MDACC cohort only (adjusted hazard ratio [aHR] 0.67, 95% CI 0.52-0.85). In subgroup analyses stratified by tumor driver mutation status, higher TDS was most consistently associated with longer PFI in BRAFV600E-mutated tumors in the MDACC cohort after adjusting for overall stage (TCGA: aHR 0.60, 95% CI 0.33-1.07; MDACC: aHR 0.59, 95% CI 0.42-0.82). For OS, increasing TDS was associated with longer OS in the overall MDACC cohort (aHR = 0.78, 95% CI 0.63-0.96), where the median duration of follow-up was 12.9 years.
Conclusion
TDS quantifies the spectrum of differentiation status in PTC and may serve as a potential prognostic biomarker in PTC, mostly promisingly in BRAFV600E-mutated tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.
- Department of Endocrine Neoplasia & Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
ORCID-Profile: Jennifer R Wang, Maria E Cabanillas, Wenyi Wang, Stephen Y Lai, Michelle D Williams
Förderung
- NCI NIH HHS
- Petrick Thyroid Cancer Research Fund
Zitieren
APA
Wang, J. R., Zafereo, M. E., Cabanillas, M. E., Wu, C. C., Xu, L., Dai, Y., Wang, W., Lai, S. Y., Henderson, Y., Erasmus, L., Williams, M. D., Joshu, C., & Ray, D. (2025). The Association Between Thyroid Differentiation Score and Survival Outcomes in Papillary Thyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism, 110(2), 356-363. https://doi.org/10.1210/clinem/dgae532
Vancouver
Wang JR, Zafereo ME, Cabanillas ME, Wu CC, Xu L, Dai Y, et al. The Association Between Thyroid Differentiation Score and Survival Outcomes in Papillary Thyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 2025;110(2):356-363. doi:10.1210/clinem/dgae532
BibTeX
@article{Wang2025,
author = {Wang, Jennifer R and Zafereo, Mark E and Cabanillas, Maria E and Wu, Chia Chin and Xu, Li and Dai, Yaoyi and Wang, Wenyi and Lai, Stephen Y and Henderson, Ying and Erasmus, Lauren and Williams, Michelle D and Joshu, Corinne and Ray, Debashree},
title = {The Association Between Thyroid Differentiation Score and Survival Outcomes in Papillary Thyroid Carcinoma},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
volume = {110},
number = {2},
pages = {356--363},
doi = {10.1210/clinem/dgae532}
}
EUVIMED